Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPARD | Q03181 | 2/20 | 0.52 |
| ▸ | TSHR | P16473 | 5/20 | 0.48 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.40 |
| ▸ | TP53 | P04637 | 1/20 | 0.37 |
| ▸ | AOX1 | Q06278 | 1/20 | 0.37 |
| ▸ | LPAR2 | Q9HBW0 | 1/20 | 0.35 |
| ▸ | LPAR3 | Q9UBY5 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | GAA | P10253 | 1/20 | 0.31 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.31 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2957697 | 0.87 | PPARD (0.48) | PPARDTSHRTDP1TP53AOX1 | |
| SCHEMBL1219734 | 0.85 | PPARD (0.47) | PPARDTSHRTDP1LPAR2LPAR3 | |
| SCHEMBL2955740 | 0.84 | LPAR3 (0.47) | PPARDTSHRTDP1LPAR2LPAR3 | |
| SCHEMBL9701750 | 0.84 | LPAR3 (0.47) | PPARDTSHRTDP1LPAR2LPAR3 | |
| SCHEMBL8993904 | 0.84 | LPAR3 (0.47) | PPARDTSHRTDP1LPAR2LPAR3 | |
| SCHEMBL2382808 | 0.79 | PPARD (0.54) | PPARDTSHRTDP1TP53AOX1 | |
| SCHEMBL9700834 | 0.78 | TDP1 (0.44) | PPARDTSHRTDP1TP53AOX1 | |
| SCHEMBL3313657 | 0.77 | PPARD (0.70) | PPARDTSHRTDP1TP53MEN1 | |
| SCHEMBL116211 | 0.77 | TSHR (0.60) | PPARDTSHRTDP1TP53AOX1 | |
| SCHEMBL23114194 | 0.76 | TSHR (0.33) | TSHRLPAR2LPAR3ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 37 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4647435-A1 | MODULATOR FOR PROMOTING BINDING OF BUTYROPHILIN 3A1/2A1 | Unicet Biotech. LLC (CN) | 2025-11-12 | — | — | EP | disclosed |
| EP-4647434-A1 | MODULATOR FOR PROMOTING BINDING OF BUTYROPHILIN 3A1/2A1 | Unicet Biotech Co., LLC (CN) | 2025-11-12 | — | — | EP | disclosed |
| US-11692079-B2 | 2-dimensional MXene particle surface-modified with functional group containing saturated or unsaturated hydrocarbon, preparation method thereof and use thereof | KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) | 2023-07-04 | — | — | US | disclosed |
| US-20230055449-A1 | FUNCTIONAL SURFACES | ORTHOBOND CORP (US) | 2023-02-23 | — | — | US | disclosed |
| EP-3525776-B1 | SURFACES WITH OLIGOMERIC OR POLYMERIC ANTIMICROBIALS | ORTHOBOND CORP (US) | 2022-01-26 | — | — | EP | disclosed |
| CN-110312507-B | Surfaces with oligomeric or polymeric antimicrobial agents | 奥索邦德公司 | 2021-11-23 | — | — | CN | disclosed |
| US-20210352903-A1 | FUNCTIONAL SURFACES | ORTHOBOND CORP (US) | 2021-11-18 | — | — | US | disclosed |
| US-11154061-B2 | Functional surfaces | Orthobond Corporation (US) | 2021-10-26 | — | — | US | disclosed |
| CN-113164370-A | Water-swellable crosslinked elastomers and methods of making and using | 迈图高新材料公司 | 2021-07-23 | — | — | CN | disclosed |
| EP-3846774-A1 | WATER SWELLABLE CROSSLINKED ELASTOMER AND METHOD OF PREPARATION AND USE | Momentive Performance Materials Inc. (US) | 2021-07-14 | — | — | EP | disclosed |
| US-7645397-B2 | Luminescent nanocomposite of luminescent nanocrystalline embedded in an epoxy, polyurea, or polyurethane matrix; retain luminescence; surfaces of nanocrystals having bound ligands comprising dicarboxylic acid moiety or aliphatic or polymeric amines; high efficiency solid-state white lighting; optics | NANOSYS, INC. (US) | 2010-01-12 | — | — | US | disclosed |
| US-20090121190-A1 | Nanocrystal Doped Matrixes | NANOSYS, INC. (US) | 2009-05-14 | — | — | US | disclosed |
| US-20090097096-A1 | ELECTROCHROMIC DEVICE USING POLYPHTHALATE AND PROCESS FOR PREPARING THE SAME | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2009-04-16 | — | — | US | disclosed |
| US-7374807-B2 | Nanocrystal doped matrixes | NANOSYS, INC. (US) | 2008-05-20 | — | — | US | disclosed |
| US-20070034833-A1 | Luminescent nanocomposite of luminescent nanocrystalline embedded in an epoxy, polyurea, or polyurethane matrix; retain luminescence; surfaces of nanocrystals having bound ligands comprising dicarboxylic acid moiety or aliphatic or polymeric amines; high efficiency solid-state white lighting; optics | NANOSYS, INC. | 2007-02-15 | — | — | US | disclosed |
| EP-0730408-A1 | TRIAZOLE PHOSPHONATE PESTICIDES | AgrEvo UK Limited (GB) | 1996-09-11 | — | — | EP | disclosed |
| WO-1995014385-A1 | TRIAZOLE PHOSPHONATE PESTICIDES | AGREVO UK LIMITED (GB) | 1995-06-01 | — | — | WO | disclosed |
| US-5166198-A | Herpes virus infections | BEECHAM P.L.C. (GB) | 1992-11-24 | — | — | US | disclosed |
| EP-0478292-A1 | Heterocyclic compounds | THE WELLCOME FOUNDATION LIMITED (GB) | 1992-04-01 | — | — | EP | disclosed |
| EP-0404296-A1 | Phosphono derivatives of purine with antiviral activity | Beecham Group p.l.c. (GB) | 1990-12-27 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230055449-A1 | FUNCTIONAL SURFACES | LPO, SELP, SIGLEC7 | PPARD 2465/4885TSHR 2514/4885TDP1 1333/4885 |
| US-11154061-B2 | Functional surfaces | LPO, SELP, SIGLEC7 | PPARD 2465/4885TSHR 2514/4885TDP1 1333/4885 |
| US-20210352903-A1 | FUNCTIONAL SURFACES | LPO, SELP, SIGLEC7 | PPARD 2465/4885TSHR 2514/4885TDP1 1333/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.